{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:22:34Z","timestamp":1795123354316,"version":"4.10.3"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C67279\/A27957"],"award-info":[{"award-number":["C67279\/A27957"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>B-cell acute lymphoblastic leukemia (B-ALL) is a leading cause of death in childhood and outcomes in adults remain dismal. There is therefore an urgent clinical need for therapies that target the highest risk cases. Mutations in the histone acetyltransferase <jats:italic>CREBBP<\/jats:italic> confer high-risk and increased chemoresistance in ALL. Performing a targeted drug-screen in isogenic human cell lines, we identify a number of small molecules that specifically target <jats:italic>CREBBP<\/jats:italic>-mutated B-ALL, the most potent being the BCL2-inhibitor Venetoclax. Of note, this acts through a non-canonical mechanism resulting in ferroptotic rather than apoptotic cell death. <jats:italic>CREBBP<\/jats:italic>-mutated cell lines show differences in cell-cycle, metabolism, lipid composition and response to oxidative stress, predisposing them to ferroptosis, which are further dysregulated upon acquisition of Venetoclax resistance. Lastly, small-molecule inhibition of CREBBP pharmacocopies <jats:italic>CREBBP<\/jats:italic>-mutation, sensitizing B-ALL cells, regardless of genotype, to Venetoclax-induced ferroptosis in-vitro and in-vivo, providing a promising drug combination for broader clinical translation in B-ALL.<\/jats:p>","DOI":"10.1038\/s41467-025-59531-6","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:15:46Z","timestamp":1747736146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["CREBBP inactivation sensitizes B cell acute lymphoblastic leukemia to ferroptotic cell death upon BCL2 inhibition"],"prefix":"10.1038","volume":"16","author":[{"given":"Alicia","family":"Garcia-Gimenez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1909-9499","authenticated-orcid":false,"given":"Jonathan E.","family":"Ditcham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9085-4031","authenticated-orcid":false,"given":"Dhoyazan M. A.","family":"Azazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1390-6592","authenticated-orcid":false,"given":"George","family":"Giotopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Asby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshwar","family":"Meduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Bagri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Sakakini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile K.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4106-2166","authenticated-orcid":false,"given":"Nisha","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tumas","family":"Beinortas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchi","family":"Agrawal-Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6835-3791","authenticated-orcid":false,"given":"Marc R.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam B. R.","family":"Alabed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0038-9709","authenticated-orcid":false,"given":"Benjamin","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9998-051X","authenticated-orcid":false,"given":"Albert","family":"Koulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1115-9618","authenticated-orcid":false,"given":"Michael P.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5783","authenticated-orcid":false,"given":"Sarah J.","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-161X","authenticated-orcid":false,"given":"Brian J. P.","family":"Huntly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4343-4784","authenticated-orcid":false,"given":"Simon E.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"59531_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger, S. P. & Mullighan, C. G. Acute lymphoblastic leukemia in children. N. Engl. J. Med. 373, 1541\u20131552 (2015).","journal-title":"N. Engl. J. Med."},{"key":"59531_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci, L. et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471, 189\u2013195 (2011).","journal-title":"Nature"},{"key":"59531_CR3","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ncb3597","volume":"19","author":"SJ Horton","year":"2017","unstructured":"Horton, S. J. et al. Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors. Nat. Cell Biol. 19, 1093\u20131104 (2017).","journal-title":"Nat. Cell Biol."},{"key":"59531_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature09727","volume":"471","author":"CG Mullighan","year":"2011","unstructured":"Mullighan, C. G. et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471, 235\u2013239 (2011).","journal-title":"Nature"},{"key":"59531_CR5","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","volume":"54","author":"SW Brady","year":"2022","unstructured":"Brady, S. W. et al. The genomic landscape of pediatric acute lymphoblastic leukemia. Nat. Genet 54, 1376\u20131389 (2022).","journal-title":"Nat. Genet"},{"key":"59531_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.2532","volume":"45","author":"L Holmfeldt","year":"2013","unstructured":"Holmfeldt, L. et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat. Genet 45, 242\u2013252 (2013).","journal-title":"Nat. Genet"},{"key":"59531_CR7","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/leu.2012.60","volume":"26","author":"A Inthal","year":"2012","unstructured":"Inthal, A. et al. CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia. Leukemia 26, 1797\u20131803 (2012).","journal-title":"Leukemia"},{"key":"59531_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1182\/blood.2019002220","volume":"135","author":"B Li","year":"2020","unstructured":"Li, B. et al. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia. Blood 135, 41\u201355 (2020).","journal-title":"Blood"},{"key":"59531_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/0008-5472.BCD-19-0041","volume":"1","author":"E Waanders","year":"2020","unstructured":"Waanders, E. et al. Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia. Blood Cancer Discov. 1, 96\u2013111 (2020).","journal-title":"Blood Cancer Discov."},{"key":"59531_CR10","first-page":"2905","volume":"22","author":"C Gao","year":"2020","unstructured":"Gao, C. et al. Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells. Mol. Med Rep. 22, 2905\u20132915 (2020).","journal-title":"Mol. Med Rep."},{"key":"59531_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41525-019-0082-y","volume":"4","author":"RA Chougule","year":"2019","unstructured":"Chougule, R. A., Shah, K., Moharram, S. A., Vallon-Christersson, J. & Kazi, J. U. Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation. NPJ Genom. Med 4, 7 (2019).","journal-title":"NPJ Genom. Med"},{"key":"59531_CR12","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3324\/haematol.2016.145177","volume":"102","author":"ZA Dixon","year":"2017","unstructured":"Dixon, Z. A. et al. CREBBP knockdown enhances RAS\/RAF\/MEK\/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response. Haematologica 102, 736\u2013745 (2017).","journal-title":"Haematologica"},{"key":"59531_CR13","first-page":"2156","volume":"141","author":"AJ Lamble","year":"2023","unstructured":"Lamble, A. J. et al. CREBBP alterations are associated with a poor prognosis in de novo AML. Blood 141, 2156\u20132159 (2023).","journal-title":"Blood"},{"key":"59531_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.977119","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. An easy-to-use nomogram predicting overall survival of adult acute lymphoblastic leukemia. Front Oncol. 12, 977119 (2022).","journal-title":"Front Oncol."},{"key":"59531_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1182\/blood-2018-07-865428","volume":"133","author":"X Qu","year":"2019","unstructured":"Qu, X. et al. Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016. Blood 133, 81\u201393 (2019).","journal-title":"Blood"},{"key":"59531_CR16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1182\/blood.2023022154","volume":"144","author":"E Balducci","year":"2024","unstructured":"Balducci, E. et al. Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL. Blood 144, 988\u20131000 (2024).","journal-title":"Blood"},{"key":"59531_CR17","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/leu.2015.107","volume":"29","author":"K Malinowska-Ozdowy","year":"2015","unstructured":"Malinowska-Ozdowy, K. et al. KRAS and CREBBP mutations: A relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia. Leukemia 29, 1656\u20131667 (2015).","journal-title":"Leukemia"},{"key":"59531_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.immuni.2019.08.006","volume":"51","author":"SN Meyer","year":"2019","unstructured":"Meyer, S. N. et al. Unique and shared epigenetic programs of the CREBBP and EP300 acetyltransferases in germinal center B cells reveal targetable dependencies in lymphoma. Immunity 51, 535\u2013547.e539 (2019).","journal-title":"Immunity"},{"key":"59531_CR19","doi-asserted-by":"publisher","unstructured":"Lord, C. J., Quinn, N. & Ryan, C. J. Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions. Elife 9 https:\/\/doi.org\/10.7554\/eLife.58925 (2020).","DOI":"10.7554\/eLife.58925"},{"key":"59531_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00018-017-2717-4","volume":"75","author":"I Dutto","year":"2018","unstructured":"Dutto, I., Scalera, C. & Prosperi, E. CREBBP and p300 lysine acetyl transferases in the DNA damage response. Cell Mol. Life Sci. 75, 1325\u20131338 (2018).","journal-title":"Cell Mol. Life Sci."},{"key":"59531_CR21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1182\/blood-2016-03-704973","volume":"128","author":"JA Irving","year":"2016","unstructured":"Irving, J. A. et al. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia. Blood 128, 911\u2013922 (2016).","journal-title":"Blood"},{"key":"59531_CR22","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-18-0236","volume":"79","author":"E Diaz-Flores","year":"2019","unstructured":"Diaz-Flores, E. et al. Bcl-2 is a therapeutic target for hypodiploid B-lineage acute lymphoblastic leukemia. Cancer Res 79, 2339\u20132351 (2019).","journal-title":"Cancer Res"},{"key":"59531_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02867-2","volume":"11","author":"A Roca-Portoles","year":"2020","unstructured":"Roca-Portoles, A. et al. Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition. Cell Death Dis. 11, 616 (2020).","journal-title":"Cell Death Dis."},{"key":"59531_CR24","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea, D. A. et al. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat. Med 24, 1859\u20131866 (2018).","journal-title":"Nat. Med"},{"key":"59531_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou, E. D. et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12, 329\u2013341 (2013).","journal-title":"Cell Stem Cell"},{"key":"59531_CR26","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","volume":"5","author":"C Fellmann","year":"2013","unstructured":"Fellmann, C. et al. An optimized microRNA backbone for effective single-copy RNAi. Cell Rep. 5, 1704\u20131713 (2013).","journal-title":"Cell Rep."},{"key":"59531_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1158\/2159-8290.CD-16-1417","volume":"7","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma. Cancer Discov. 7, 322\u2013337 (2017).","journal-title":"Cancer Discov."},{"key":"59531_CR28","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1038\/nprot.2013.150","volume":"8","author":"S Wang","year":"2013","unstructured":"Wang, S. et al. Target analysis by integration of transcriptome and ChIP-seq data with BETA. Nat. Protoc. 8, 2502\u20132515 (2013).","journal-title":"Nat. Protoc."},{"key":"59531_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"59531_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2023.01.020","volume":"186","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. Human hematopoietic stem cell vulnerability to ferroptosis. Cell 186, 732\u2013747.e716 (2023).","journal-title":"Cell"},{"key":"59531_CR31","doi-asserted-by":"publisher","first-page":"e0154605","DOI":"10.1371\/journal.pone.0154605","volume":"11","author":"H Huo","year":"2016","unstructured":"Huo, H. et al. Erastin disrupts mitochondrial permeability transition pore (mPTP) and induces apoptotic death of colorectal cancer cells. PLoS One 11, e0154605 (2016).","journal-title":"PLoS One"},{"key":"59531_CR32","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda, N. et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447, 864\u2013868 (2007).","journal-title":"Nature"},{"key":"59531_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3324\/haematol.2022.280786","volume":"108","author":"ME Lalonde","year":"2023","unstructured":"Lalonde, M. E. et al. Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia. Haematologica 108, 382\u2013393 (2023).","journal-title":"Haematologica"},{"key":"59531_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.brainresbull.2022.08.008","volume":"188","author":"J Udagawa","year":"2022","unstructured":"Udagawa, J. & Hino, K. Plasmalogen in the brain: Effects on cognitive functions and behaviors attributable to its properties. Brain Res. Bull. 188, 197\u2013202 (2022).","journal-title":"Brain Res. Bull."},{"key":"59531_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37924-9","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis. Nat. Commun. 14, 2194 (2023).","journal-title":"Nat. Commun."},{"key":"59531_CR36","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1038\/s41418-021-00769-0","volume":"28","author":"W Cui","year":"2021","unstructured":"Cui, W., Liu, D., Gu, W. & Chu, B. Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis. Cell Death Differ. 28, 2536\u20132551 (2021).","journal-title":"Cell Death Differ."},{"key":"59531_CR37","doi-asserted-by":"publisher","first-page":"e1010436","DOI":"10.1371\/journal.pgen.1010436","volume":"18","author":"MA Perez","year":"2022","unstructured":"Perez, M. A. et al. Ether lipid deficiency disrupts lipid homeostasis leading to ferroptosis sensitivity. PLoS Genet 18, e1010436 (2022).","journal-title":"PLoS Genet"},{"key":"59531_CR38","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts, K. G. et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N. Engl. J. Med. 371, 1005\u20131015 (2014).","journal-title":"N. Engl. J. Med"},{"key":"59531_CR39","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou, Y. et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature 585, 603\u2013608 (2020).","journal-title":"Nature"},{"key":"59531_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03170-7","volume":"9","author":"CD Herling","year":"2018","unstructured":"Herling, C. D. et al. Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia. Nat. Commun. 9, 727 (2018).","journal-title":"Nat. Commun."},{"key":"59531_CR41","doi-asserted-by":"publisher","unstructured":"Shoshan-Barmatz, V., Shteinfer-Kuzmine, A. & Verma, A. VDAC1 at the intersection of cell metabolism, apoptosis, and diseases. Biomolecules 10 https:\/\/doi.org\/10.3390\/biom10111485 (2020).","DOI":"10.3390\/biom10111485"},{"key":"59531_CR42","doi-asserted-by":"publisher","first-page":"11920","DOI":"10.1074\/jbc.M112.433847","volume":"288","author":"EN Maldonado","year":"2013","unstructured":"Maldonado, E. N. et al. Voltage-dependent anion channels modulate mitochondrial metabolism in cancer cells: Regulation by free tubulin and erastin. J. Biol. Chem. 288, 11920\u201311929 (2013).","journal-title":"J. Biol. Chem."},{"key":"59531_CR43","doi-asserted-by":"publisher","unstructured":"Place, A. E. et al. Pediatric patients with relapsed\/refractory acute lymphoblastic leukemia harboring heterogeneous genomic profiles respond to venetoclax in combination with chemotherapy. Blood 136 https:\/\/doi.org\/10.1182\/blood-2020-137376 (2020).","DOI":"10.1182\/blood-2020-137376"},{"key":"59531_CR44","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.molcel.2023.03.005","volume":"83","author":"SJ Dixon","year":"2023","unstructured":"Dixon, S. J. & Pratt, D. A. Ferroptosis: A flexible constellation of related biochemical mechanisms. Mol. Cell 83, 1030\u20131042 (2023).","journal-title":"Mol. Cell"},{"key":"59531_CR45","first-page":"2703","volume":"10","author":"GV Borzillo","year":"1990","unstructured":"Borzillo, G. V., Ashmun, R. A. & Sherr, C. J. Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes. Mol. Cell Biol. 10, 2703\u20132714 (1990).","journal-title":"Mol. Cell Biol."},{"key":"59531_CR46","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1182\/blood.V95.3.745.003k05_745_755","volume":"95","author":"GA Blobel","year":"2000","unstructured":"Blobel, G. A. CREB-binding protein and p300: Molecular integrators of hematopoietic transcription. Blood 95, 745\u2013755 (2000).","journal-title":"Blood"},{"key":"59531_CR47","doi-asserted-by":"publisher","first-page":"8537","DOI":"10.1074\/jbc.M109.083311","volume":"285","author":"M Honsho","year":"2010","unstructured":"Honsho, M., Asaoku, S. & Fujiki, Y. Posttranslational regulation of fatty acyl-CoA reductase 1, Far1, controls ether glycerophospholipid synthesis. J. Biol. Chem. 285, 8537\u20138542 (2010).","journal-title":"J. Biol. Chem."},{"key":"59531_CR48","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1046\/j.1432-1327.1999.00295.x","volume":"261","author":"J Biermann","year":"1999","unstructured":"Biermann, J., Just, W. W., Wanders, R. J. & Van Den Bosch, H. Alkyl-dihydroxyacetone phosphate synthase and dihydroxyacetone phosphate acyltransferase form a protein complex in peroxisomes. Eur. J. Biochem 261, 492\u2013499 (1999).","journal-title":"Eur. J. Biochem"},{"key":"59531_CR49","doi-asserted-by":"publisher","unstructured":"Brooks, N. et al. CCS1477, a novel p300\/CBP bromodomain inhibitor, enhances efficacy of azacitidine and venetoclax in pre-clinical models of acute myeloid leukaemia and lymphoma. Blood 138 https:\/\/doi.org\/10.1182\/blood-2021-148295 (2021).","DOI":"10.1182\/blood-2021-148295"},{"key":"59531_CR50","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.ccell.2023.11.001","volume":"41","author":"L Nicosia","year":"2023","unstructured":"Nicosia, L. et al. Therapeutic targeting of EP300\/CBP by bromodomain inhibition in hematologic malignancies. Cancer Cell 41, 2136\u20132153.e2113 (2023).","journal-title":"Cancer Cell"},{"key":"59531_CR51","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","volume":"20","author":"S Zheng","year":"2022","unstructured":"Zheng, S. et al. SynergyFinder Plus: Toward better interpretation and annotation of drug combination screening datasets. Genomics Proteom. Bioinforma. 20, 587\u2013596 (2022).","journal-title":"Genomics Proteom. Bioinforma."},{"key":"59531_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-12-2","volume":"12","author":"A Sakaue-Sawano","year":"2011","unstructured":"Sakaue-Sawano, A., Kobayashi, T., Ohtawa, K. & Miyawaki, A. Drug-induced cell cycle modulation leading to cell-cycle arrest, nuclear mis-segregation, or endoreplication. BMC Cell Biol. 12, 2 (2011).","journal-title":"BMC Cell Biol."},{"key":"59531_CR53","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.chembiol.2008.10.015","volume":"15","author":"A Sakaue-Sawano","year":"2008","unstructured":"Sakaue-Sawano, A. et al. Tracing the silhouette of individual cells in S\/G2\/M phases with fluorescence. Chem. Biol. 15, 1243\u20131248 (2008).","journal-title":"Chem. Biol."},{"key":"59531_CR54","doi-asserted-by":"publisher","unstructured":"Jenkins, B., Ronis, M. & Koulman, A. LC-MS Lipidomics: Exploiting a simple high-throughput method for the comprehensive extraction of lipids in a ruminant fat dose-response study. Metabolites 10 https:\/\/doi.org\/10.3390\/metabo10070296 (2020).","DOI":"10.3390\/metabo10070296"},{"key":"59531_CR55","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41587-020-0531-2","volume":"38","author":"H Tsugawa","year":"2020","unstructured":"Tsugawa, H. et al. A lipidome atlas in MS-DIAL 4. Nat. Biotechnol. 38, 1159\u20131163 (2020).","journal-title":"Nat. Biotechnol."},{"key":"59531_CR56","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/bioinformatics\/btab867","volume":"38","author":"RM Pellegrino","year":"2022","unstructured":"Pellegrino, R. M. et al. LipidOne: User-friendly lipidomic data analysis tool for a deeper interpretation in a systems biology scenario. Bioinformatics 38, 1767\u20131769 (2022).","journal-title":"Bioinformatics"},{"key":"59531_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.70009","volume":"4","author":"HBR Alabed","year":"2024","unstructured":"Alabed, H. B. R. et al. LipidOne 2.0: A web tool for discovering biological meanings hidden in lipidomic data. Curr. Protoc. 4, e70009 (2024).","journal-title":"Curr. Protoc."},{"key":"59531_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"59531_CR59","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"59531_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"59531_CR61","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"59531_CR62","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"59531_CR63","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"59531_CR64","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"59531_CR65","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ramirez","year":"2016","unstructured":"Ramirez, F. et al. deepTools2: A next generation web server for deep-sequencing data analysis. Nucleic Acids Res 44, W160\u2013W165 (2016).","journal-title":"Nucleic Acids Res"},{"key":"59531_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1802-4","volume":"20","author":"Q Zhu","year":"2019","unstructured":"Zhu, Q., Liu, N., Orkin, S. H. & Yuan, G. C. CUT&RUNTools: A flexible pipeline for CUT&RUN processing and footprint analysis. Genome Biol. 20, 192 (2019).","journal-title":"Genome Biol."},{"key":"59531_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"59531_CR68","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/bioinformatics\/bts277","volume":"28","author":"S Neph","year":"2012","unstructured":"Neph, S. et al. BEDOPS: High-performance genomic feature operations. Bioinformatics 28, 1919\u20131920 (2012).","journal-title":"Bioinformatics"},{"key":"59531_CR69","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L. G. & He, Q. Y. ChIPseeker: An R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383 (2015).","journal-title":"Bioinformatics"},{"key":"59531_CR70","doi-asserted-by":"publisher","first-page":"950","DOI":"10.12688\/f1000research.8759.1","volume":"5","author":"AT Lun","year":"2016","unstructured":"Lun, A. T., Perry, M. & Ing-Simmons, E. Infrastructure for genomic interactions: Bioconductor classes for Hi-C, ChIA-PET and related experiments. F1000Res 5, 950 (2016).","journal-title":"F1000Res"},{"key":"59531_CR71","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1093\/bioinformatics\/btq351","volume":"26","author":"WJ Kent","year":"2010","unstructured":"Kent, W. J., Zweig, A. S., Barber, G., Hinrichs, A. S. & Karolchik, D. BigWig and BigBed: Enabling browsing of large distributed datasets. Bioinformatics 26, 2204\u20132207 (2010).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59531-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59531-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59531-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:15:47Z","timestamp":1747736147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59531-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59531"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59531-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.N. is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to Venetoclax. N.N. received payments from WEHI related to Venetoclax. The combination of BCL2 and CREBBP\/EP300 inhibitors in ALL is protected under Cambridge Enterprise patent PCT\/GB2024\/052398 (S.E.R. and B.P.J.H. listed inventors). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4274"}}